StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2022 it was $118.44K, up 372.8% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2022Dec 31, 2022$118.44K+372.8%
FY2021Dec 31, 2021$25.05K–

More TFA Therapeutics figures

See a number that looks wrong?